查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1579984

心臟组织工程市场：按材料类型、技术、组件、最终用户、应用划分 - 全球预测 2025-2030

Cardiac Tissue Engineering Market by Material Type, Technology, Component, End User, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年心臟组织工程市场价值为96.8亿美元，预计到2024年将达到104.5亿美元，复合年增长率为8.52%，到2030年将达到171.6亿美元。

心臟组织工程涉及创建生物人工组织来修復或取代受损的心臟组织，代表着治疗心血管疾病的突破，而心血管疾病是全球死亡的主要原因。该领域结合了生物医学工程、材料科学和细胞生物学的原理，透过组织重塑和再生来解决心臟衰竭和心肌梗塞问题。这项技术的需求源于当前心臟病治疗的重大限制，包括捐赠器官的短缺和与移植相关的併发症。其应用范围从药物测试的实验室模型到治疗性植入和再生疗法。最终用途范围主要包括研究机构、生物製药公司和医疗保健产业。影响市场成长的主要因素包括增加研发投资、提高细胞相容性的生物材料的进步以及心血管疾病盛行率的上升。商机在于3D生物列印和创新支架材料开发等技术突破。为了利用这些优势，相关人员可以专注于与大学和研究中心的合作，以促进创新和长期成长。然而，高昂的研究成本、临床应用的挑战以及严格的监管途径等限制因素带来了巨大的挑战。围绕干细胞的使用以及将技术融入传统医疗实践的伦理担忧也阻碍了市场的成长。儘管如此，该领域的创新时机已经成熟，特别是奈米功能化生物材料的开发和改进的细胞采购技术。为了实现业务成长，投资扩充性的製造流程和个人化医疗方法可以产生高回报。对这个市场的洞察表明，这是一个充满活力且不断发展的市场，在技术进步和不断增长的医疗保健需求的推动下具有巨大的成长潜力。

主要市场统计
基准年[2023] 96.8亿美元
预测年份 [2024] 104.5亿美元
预测年份 [2030] 171.6亿美元
复合年增长率（%） 8.52%

市场动态：揭示快速发展的心臟组织工程市场的关键市场洞察

供需的动态交互作用正在改变心臟组织工程市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 全球心血管疾病盛行率不断上升
    • 提高临床医生和患者对组织工程在心臟病治疗中的益处和潜力的认识和接受度
  • 市场限制因素
    • 与创建功能组织相关的技术挑战和复杂性
  • 市场机会
    • 增加对再生医学领域的资金和投资，以支持研究和开发活动。
    • 生物技术公司、学术机构和研究机构之间的策略合作和伙伴关係，以推动创新
  • 市场挑战
    • 严格的监管环境和长期的临床试验

波特的五力：驾驭心臟组织工程市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解心臟组织工程市场的外部影响

外部宏观环境因素在塑造心臟组织工程市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解心臟组织工程市场的竞争格局

对心臟组织工程市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵心臟组织工程市场供应商绩效评估

FPNV定位矩阵是评估心臟组织工程市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，以规划心臟组织工程市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对心臟组织工程市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球心血管疾病盛行率增加
      • 提高临床医生和患者对组织工程治疗心臟病的益处和潜力的认识和接受度
    • 抑制因素
      • 创建职能组织涉及的技术挑战和复杂性
    • 机会
      • 增加资金和投资，支持再生医学领域的研发活动
      • 生物技术公司、学术机构和研究机构之间的策略合作和伙伴关係，以推动创新
    • 任务
      • 严格的监管环境和长期的临床试验
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章依材料类型分類的心臟组织工程市场

  • 未来的材料
    • 先进生医材料
    • 奈米复合材料
  • 混合材料
    • 生物合成混合物
  • 天然聚合物
    • 几丁聚醣
    • 胶原蛋白
    • 纤维蛋白
    • 明胶
  • 合成聚合物
    • 聚己内酯
    • 聚乙二醇
    • Polyglycolic
    • 聚乳酸

第七章心臟组织工程市场：依技术分类

  • 3D生物列印
    • 喷墨生物列印
    • 雷射辅助生物列印
    • 微挤压生物列印
  • 心臟组织工程模型
    • 体外模型
    • 生物模型
  • 细胞培养技术
    • QR 图文化
    • 3D文化
    • 类器官培养

第八章心臟组织工程市场：依组成部分

  • 细胞培养套件和培养基
  • 细胞支架
  • 生长因子

第九章心臟组织工程市场：依最终使用者分类

  • 学术研究所
    • 研究医院
    • 大学实验室
  • 生技公司
    • 心臟设备製造商
    • 组织工程Start-Ups

第10章心臟组织工程市场：依应用分类

  • 临床应用
    • 心臟再生
    • 心臟修復
    • 阀门工程
  • 药品应用
    • 药物发现
    • 个人化医疗
  • 调查申请
    • 疾病建模
    • 毒性评估

第十一章美洲心臟组织工程市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太地区心臟组织工程市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲心臟组织工程市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Cellino Biotech 的 NEBULA计划已从 ARPA-H 获得 2500 万美元的资金，以彻底改变再生医学。
    • ATCC 和 Tissue Dynamics 的先进人工智慧驱动心臟类器官模型旨在彻底改变药物开发
    • FluidForm Bio 透过创新的 FRESH 3D 生物列印推进心臟组织工程
  • 战略分析和建议
    • 雅培实验室

公司名单

  • Abbott Laboratories
  • Atrivion, Inc.
  • Auto Tissue Berlin GmbH
  • Avery Therapeutics, Inc.
  • Axol Bioscience Ltd.
  • Baxter International Inc.
  • BioCardia, Inc.
  • Cytograft Tissue Engineering, Inc.
  • Fujifilm Holdings Corporation
  • Heartseed Inc.
  • Humacyte, Inc.
  • Medtronic plc
  • Merck KGaA
  • Meril Lifesciences Pvt. Ltd.
  • Nanofiber Solutions
  • Organovo Holdings, Inc.
  • Regenovo Biotechnology Co., Ltd.
  • REPROCELL Inc.
  • Teijin Limited
  • Terumo Corporation
  • TissUse GmbH
  • Valo Health, Inc.
Product Code: MRR-DE0D254C1B76

The Cardiac Tissue Engineering Market was valued at USD 9.68 billion in 2023, expected to reach USD 10.45 billion in 2024, and is projected to grow at a CAGR of 8.52%, to USD 17.16 billion by 2030.

Cardiac Tissue Engineering involves creating bioartificial tissues to repair or replace damaged heart tissues, presenting a revolutionary advancement for treating cardiovascular diseases, the leading cause of death globally. This field merges principles from biomedical engineering, material science, and cell biology to enable tissue reconstruction and regeneration, hence addressing heart failure or myocardial infarction. The necessity of this technology arises from the significant limitations of current heart disease treatments, such as donor organ scarcity and transplantation-related complications. Its applications range from laboratory models for drug testing to therapeutic implants and regenerative therapies. The end-use scope primarily includes research institutions, biopharmaceutical companies, and healthcare sectors. Key factors influencing market growth include increased investment in R&D, advances in biomaterials that enhance cell compatibility, and rising prevalence of cardiovascular disorders. Opportunities lie within technological breakthroughs like 3D bioprinting and the development of innovative scaffolding materials. To leverage these, stakeholders can focus on partnerships with universities and research centers to foster innovation and long-term growth. However, limitations such as the high cost of research and clinical translation challenges, along with stringent regulatory pathways, present formidable challenges. Market growth is also hindered by ethical concerns over stem cell use and technology integration into traditional medical practices. Still, the sector remains ripe for innovation, particularly in the development of nano-functionalized biomaterials and improved cell sourcing techniques. For business growth, investing in scalable manufacturing processes and personalized medicine approaches could yield high returns. Insight into this market reveals it as dynamic yet nascent, with significant potential growth driven by technological advancements and increasing healthcare demands, requiring strategic navigation of regulatory, ethical, and technical challenges to realize its full potential.

KEY MARKET STATISTICS
Base Year [2023] USD 9.68 billion
Estimated Year [2024] USD 10.45 billion
Forecast Year [2030] USD 17.16 billion
CAGR (%) 8.52%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cardiac Tissue Engineering Market

The Cardiac Tissue Engineering Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of cardiovascular diseases globally
    • Increasing awareness and acceptance among clinicians and patients about the benefits and potential of tissue engineering in treating heart disease
  • Market Restraints
    • Technical challenges and complexities associated with creation of functional tissues
  • Market Opportunities
    • Increased funding and investment in the field of regenerative medicine to support research and development activities
    • Strategic collaboration and partnerships among biotech companies, academic institutions, and research organizations to drive innovation
  • Market Challenges
    • Stringent regulatory landscape and prolonged clinical trials

Porter's Five Forces: A Strategic Tool for Navigating the Cardiac Tissue Engineering Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cardiac Tissue Engineering Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cardiac Tissue Engineering Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cardiac Tissue Engineering Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cardiac Tissue Engineering Market

A detailed market share analysis in the Cardiac Tissue Engineering Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cardiac Tissue Engineering Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cardiac Tissue Engineering Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cardiac Tissue Engineering Market

A strategic analysis of the Cardiac Tissue Engineering Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cardiac Tissue Engineering Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Atrivion, Inc., Auto Tissue Berlin GmbH, Avery Therapeutics, Inc., Axol Bioscience Ltd., Baxter International Inc., BioCardia, Inc., Cytograft Tissue Engineering, Inc., Fujifilm Holdings Corporation, Heartseed Inc., Humacyte, Inc., Medtronic plc, Merck KGaA, Meril Lifesciences Pvt. Ltd., Nanofiber Solutions, Organovo Holdings, Inc., Regenovo Biotechnology Co., Ltd., REPROCELL Inc., Teijin Limited, Terumo Corporation, TissUse GmbH, and Valo Health, Inc..

Market Segmentation & Coverage

This research report categorizes the Cardiac Tissue Engineering Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Material Type, market is studied across Future Materials, Hybrid Materials, Natural Polymers, and Synthetic Polymers. The Future Materials is further studied across Advanced Biomaterials and Nano-composite Materials. The Hybrid Materials is further studied across Bio-Synthetic Blends. The Natural Polymers is further studied across Chitosan, Collagen, Fibrin, and Gelatin. The Synthetic Polymers is further studied across Polycaprolactone, Polyethylene Glycol, Polyglycolic Acid, and Polylactic Acid.
  • Based on Technology, market is studied across 3D Bioprinting, Cardiac Tissue Engineering Models, and Cell Culture Techniques. The 3D Bioprinting is further studied across Inkjet Bioprinting, Laser-Assisted Bioprinting, and Microextrusion Bioprinting. The Cardiac Tissue Engineering Models is further studied across In Vitro Models and In Vivo Models. The Cell Culture Techniques is further studied across 2D Culture, 3D Culture, and Organoid Cultures.
  • Based on Component, market is studied across Cell Culture Kits & Media, Cell Scaffolds, and Growth Factors.
  • Based on End User, market is studied across Academic & Research Institutes and Biotechnology Companies. The Academic & Research Institutes is further studied across Research Hospitals and University Laboratories. The Biotechnology Companies is further studied across Cardiac Device Manufacturers and Tissue Engineering Startups.
  • Based on Application, market is studied across Clinical Applications, Pharmaceutical Applications, and Research Applications. The Clinical Applications is further studied across Heart Regeneration, Heart Repair, and Valve Engineering. The Pharmaceutical Applications is further studied across Drug Discovery and Personalized Medicine. The Research Applications is further studied across Disease Modelling and Toxicology Assessment.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of cardiovascular diseases globally
      • 5.1.1.2. Increasing awareness and acceptance among clinicians and patients about the benefits and potential of tissue engineering in treating heart disease
    • 5.1.2. Restraints
      • 5.1.2.1. Technical challenges and complexities associated with creation of functional tissues
    • 5.1.3. Opportunities
      • 5.1.3.1. Increased funding and investment in the field of regenerative medicine to support research and development activities
      • 5.1.3.2. Strategic collaboration and partnerships among biotech companies, academic institutions, and research organizations to drive innovation
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory landscape and prolonged clinical trials
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cardiac Tissue Engineering Market, by Material Type

  • 6.1. Introduction
  • 6.2. Future Materials
    • 6.2.1. Advanced Biomaterials
    • 6.2.2. Nano-composite Materials
  • 6.3. Hybrid Materials
    • 6.3.1. Bio-Synthetic Blends
  • 6.4. Natural Polymers
    • 6.4.1. Chitosan
    • 6.4.2. Collagen
    • 6.4.3. Fibrin
    • 6.4.4. Gelatin
  • 6.5. Synthetic Polymers
    • 6.5.1. Polycaprolactone
    • 6.5.2. Polyethylene Glycol
    • 6.5.3. Polyglycolic Acid
    • 6.5.4. Polylactic Acid

7. Cardiac Tissue Engineering Market, by Technology

  • 7.1. Introduction
  • 7.2. 3D Bioprinting
    • 7.2.1. Inkjet Bioprinting
    • 7.2.2. Laser-Assisted Bioprinting
    • 7.2.3. Microextrusion Bioprinting
  • 7.3. Cardiac Tissue Engineering Models
    • 7.3.1. In Vitro Models
    • 7.3.2. In Vivo Models
  • 7.4. Cell Culture Techniques
    • 7.4.1. 2D Culture
    • 7.4.2. 3D Culture
    • 7.4.3. Organoid Cultures

8. Cardiac Tissue Engineering Market, by Component

  • 8.1. Introduction
  • 8.2. Cell Culture Kits & Media
  • 8.3. Cell Scaffolds
  • 8.4. Growth Factors

9. Cardiac Tissue Engineering Market, by End User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
    • 9.2.1. Research Hospitals
    • 9.2.2. University Laboratories
  • 9.3. Biotechnology Companies
    • 9.3.1. Cardiac Device Manufacturers
    • 9.3.2. Tissue Engineering Startups

10. Cardiac Tissue Engineering Market, by Application

  • 10.1. Introduction
  • 10.2. Clinical Applications
    • 10.2.1. Heart Regeneration
    • 10.2.2. Heart Repair
    • 10.2.3. Valve Engineering
  • 10.3. Pharmaceutical Applications
    • 10.3.1. Drug Discovery
    • 10.3.2. Personalized Medicine
  • 10.4. Research Applications
    • 10.4.1. Disease Modelling
    • 10.4.2. Toxicology Assessment

11. Americas Cardiac Tissue Engineering Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Cardiac Tissue Engineering Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Cardiac Tissue Engineering Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Cellino Biotech's NEBULA project secures USD 25 million funding from ARPA-H to revolutionize regenerative medicine
    • 14.3.2. Advanced AI-Driven cardiac organoid model by ATCC and Tissue Dynamics aims to revolutionize drug development
    • 14.3.3. FluidForm Bio advances cardiac tissue engineering with Innovative FRESH 3D Bioprinting
  • 14.4. Strategy Analysis & Recommendation
    • 14.4.1. Abbott Laboratories

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Atrivion, Inc.
  • 3. Auto Tissue Berlin GmbH
  • 4. Avery Therapeutics, Inc.
  • 5. Axol Bioscience Ltd.
  • 6. Baxter International Inc.
  • 7. BioCardia, Inc.
  • 8. Cytograft Tissue Engineering, Inc.
  • 9. Fujifilm Holdings Corporation
  • 10. Heartseed Inc.
  • 11. Humacyte, Inc.
  • 12. Medtronic plc
  • 13. Merck KGaA
  • 14. Meril Lifesciences Pvt. Ltd.
  • 15. Nanofiber Solutions
  • 16. Organovo Holdings, Inc.
  • 17. Regenovo Biotechnology Co., Ltd.
  • 18. REPROCELL Inc.
  • 19. Teijin Limited
  • 20. Terumo Corporation
  • 21. TissUse GmbH
  • 22. Valo Health, Inc.

LIST OF FIGURES

  • FIGURE 1. CARDIAC TISSUE ENGINEERING MARKET RESEARCH PROCESS
  • FIGURE 2. CARDIAC TISSUE ENGINEERING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MATERIAL TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MATERIAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. CARDIAC TISSUE ENGINEERING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. CARDIAC TISSUE ENGINEERING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CARDIAC TISSUE ENGINEERING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CARDIAC TISSUE ENGINEERING MARKET DYNAMICS
  • TABLE 7. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY FUTURE MATERIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ADVANCED BIOMATERIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY NANO-COMPOSITE MATERIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY FUTURE MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HYBRID MATERIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIO-SYNTHETIC BLENDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HYBRID MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY NATURAL POLYMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CHITOSAN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COLLAGEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY FIBRIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY GELATIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY NATURAL POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY SYNTHETIC POLYMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY POLYCAPROLACTONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY POLYETHYLENE GLYCOL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY POLYGLYCOLIC ACID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY POLYLACTIC ACID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY INKJET BIOPRINTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY LASER-ASSISTED BIOPRINTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MICROEXTRUSION BIOPRINTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC TISSUE ENGINEERING MODELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY IN VITRO MODELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY IN VIVO MODELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC TISSUE ENGINEERING MODELS, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL CULTURE TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 2D CULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D CULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ORGANOID CULTURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL CULTURE KITS & MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL SCAFFOLDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY RESEARCH HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY UNIVERSITY LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC DEVICE MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TISSUE ENGINEERING STARTUPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CLINICAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HEART REGENERATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 58. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HEART REPAIR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 59. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY VALVE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 60. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 61. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PHARMACEUTICAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 62. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 63. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 64. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PHARMACEUTICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 65. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 66. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY DISEASE MODELLING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 67. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TOXICOLOGY ASSESSMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 68. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 69. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY FUTURE MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 71. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HYBRID MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 72. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY NATURAL POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 73. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 74. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
  • TABLE 76. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC TISSUE ENGINEERING MODELS, 2018-2030 (USD MILLION)
  • TABLE 77. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 78. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 79. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 81. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 82. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 84. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PHARMACEUTICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 85. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 86. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY FUTURE MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 89. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HYBRID MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 90. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY NATURAL POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 91. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 92. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
  • TABLE 94. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC TISSUE ENGINEERING MODELS, 2018-2030 (USD MILLION)
  • TABLE 95. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 96. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 97. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 99. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 100. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 102. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PHARMACEUTICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 103. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 104. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY FUTURE MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 106. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HYBRID MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 107. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY NATURAL POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 108. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 109. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
  • TABLE 111. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC TISSUE ENGINEERING MODELS, 2018-2030 (USD MILLION)
  • TABLE 112. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 113. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 114. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 116. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 117. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 119. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PHARMACEUTICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 120. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 121. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY FUTURE MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 123. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HYBRID MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 124. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY NATURAL POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 125. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 126. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
  • TABLE 128. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC TISSUE ENGINEERING MODELS, 2018-2030 (USD MILLION)
  • TABLE 129. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 130. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 131. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 133. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 134. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 136. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PHARMACEUTICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 137. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 138. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY FUTURE MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 140. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HYBRID MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 141. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY NATURAL POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 142. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 143. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 144. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
  • TABLE 145. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC TISSUE ENGINEERING MODELS, 2018-2030 (USD MILLION)
  • TABLE 146. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 147. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 148. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 150. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 151. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 153. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PHARMACEUTICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 154. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 155. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY FUTURE MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 157. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HYBRID MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 158. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY NATURAL POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 159. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 160. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
  • TABLE 162. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC TISSUE ENGINEERING MODELS, 2018-2030 (USD MILLION)
  • TABLE 163. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 164. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 165. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 167. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 168. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 170. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PHARMACEUTICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 171. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 172. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY FUTURE MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HYBRID MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY NATURAL POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC TISSUE ENGINEERING MODELS, 2018-2030 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PHARMACEUTICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 191. AUSTRALIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. AUSTRALIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY FUTURE MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 193. AUSTRALIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HYBRID MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 194. AUSTRALIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY NATURAL POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 195. AUSTRALIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 196. AUSTRALIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. AUSTRALIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
  • TABLE 198. AUSTRALIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC TISSUE ENGINEERING MODELS, 2018-2030 (USD MILLION)
  • TABLE 199. AUSTRALIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 200. AUSTRALIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 201. AUSTRALIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 202. AUSTRALIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 203. AUSTRALIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 204. AUSTRALIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. AUSTRALIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 206. AUSTRALIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PHARMACEUTICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 207. AUSTRALIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 208. CHINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. CHINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY FUTURE MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 210. CHINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HYBRID MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 211. CHINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY NATURAL POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 212. CHINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 213. CHINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 214. CHINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
  • TABLE 215. CHINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC TISSUE ENGINEERING MODELS, 2018-2030 (USD MILLION)
  • TABLE 216. CHINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 217. CHINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 218. CHINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 219. CHINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 220. CHINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 221. CHINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. CHINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 223. CHINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PHARMACEUTICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 224. CHINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 225. INDIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. INDIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY FUTURE MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 227. INDIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HYBRID MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 228. INDIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY NATURAL POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 229. INDIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 230. INDIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 231. INDIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
  • TABLE 232. INDIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC TISSUE ENGINEERING MODELS, 2018-2030 (USD MILLION)
  • TABLE 233. INDIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 234. INDIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 235. INDIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 236. INDIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 237. INDIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 238. INDIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 239. INDIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 240. INDIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PHARMACEUTICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 241. INDIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 242. INDONESIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. INDONESIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY FUTURE MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 244. INDONESIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HYBRID MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 245. INDONESIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY NATURAL POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 246. INDONESIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 247. INDONESIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 248. INDONESIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
  • TABLE 249. INDONESIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC TISSUE ENGINEERING MODELS, 2018-2030 (USD MILLION)
  • TABLE 250. INDONESIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 251. INDONESIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 252. INDONESIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 253. INDONESIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 254. INDONESIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 255. INDONESIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 256. INDONESIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 257. INDONESIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PHARMACEUTICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 258. INDONESIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 259. JAPAN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. JAPAN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY FUTURE MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 261. JAPAN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HYBRID MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 262. JAPAN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY NATURAL POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 263. JAPAN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 264. JAPAN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 265. JAPAN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
  • TABLE 266. JAPAN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC TISSUE ENGINEERING MODELS, 2018-2030 (USD MILLION)
  • TABLE 267. JAPAN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 268. JAPAN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 269. JAPAN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 270. JAPAN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 271. JAPAN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 272. JAPAN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 273. JAPAN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 274. JAPAN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PHARMACEUTICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 275. JAPAN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 276. MALAYSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. MALAYSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY FUTURE MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 278. MALAYSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HYBRID MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 279. MALAYSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY NATURAL POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 280. MALAYSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 281. MALAYSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 282. MALAYSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
  • TABLE 283. MALAYSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC TISSUE ENGINEERING MODELS, 2018-2030 (USD MILLION)
  • TABLE 284. MALAYSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 285. MALAYSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 286. MALAYSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 287. MALAYSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 288. MALAYSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 289. MALAYSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 290. MALAYSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 291. MALAYSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PHARMACEUTICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 292. MALAYSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 293. PHILIPPINES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 294. PHILIPPINES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY FUTURE MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 295. PHILIPPINES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HYBRID MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 296. PHILIPPINES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY NATURAL POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 297. PHILIPPINES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
  • TABLE 298. PHILIPPINES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 299. PHILIPPINES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
  • TABLE 300. PHILIPPINES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC TISSUE ENGINEERING MODELS, 2018-2030 (USD MILLION)
  • TABLE 301. PHILIPPINES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 302. PHILIPPINES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 303. PHILIPPINES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 304. PHILIPPINES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 305. PHILIPPINES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 306. PHILIPPINES CARDIAC TISSUE ENGINEERI